Top 10 HIV/AIDS-Related Clinical Developments of 2011 (December 1, 2011)
David Alain Wohl, M.D., on HIV treatment as prevention; the dawning of pre-exposure prophylaxis (PrEP), but with women absent; the concept of "viremia copy-years"; the impact of race and gender on HIV treatment outcomes; setbacks for two treatment approaches involving Isentress; new hepatitis C therapies; a new once-daily HIV pill; the rising rates of HIV among black MSM; and what comes after "test and treat."
B-Tripla and a Bluey on Bondi Beach: A Blog Entry by Bob Frascino, M.D. (April 7, 2011)
"[Bronzed Aussie Surfer Dude:] It's been like a century since we've had a new HIV drug. What's up with that? Dr. Bob: Well, in reality it's been three years since the last new antiretrovirals hit the market. But I agree three years is a bit of a dry spell. The good news is that a new NNRTI is on its way to pharmacy shelves very soon."
TheBody is a service of Remedy Health Media, 461 Fifth Avenue, 14th Floor, New York, NY 10017. TheBody and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBody's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBody is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.